Puma Biotechnology, Inc.PBYINASDAQ
Loading
Year-over-year earnings per share growth rate
5Y CAGR
-0.7%/yr
Long-term compound
Percentile
P62
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 qtr
Consecutive growthStable
| Period | Value |
|---|---|
| Q4 2025 | 50.00% |
| Q3 2025 | 50.00% |
| Q2 2025 | 100.00% |
| Q1 2025 | -84.62% |
| Q4 2024 | -4.88% |
| Q3 2024 | 537.10% |
| Q2 2024 | 6.11% |
| Q1 2024 | -138.42% |
| Q4 2023 | 116.67% |
| Q3 2023 | 163.74% |
| Q2 2023 | 51.67% |
| Q1 2023 | 125.00% |
| Q4 2022 | -1418.99% |
| Q3 2022 | -103.76% |
| Q2 2022 | 360.55% |
| Q1 2022 | -180.60% |
| Q4 2021 | 109.17% |
| Q3 2021 | -738.46% |
| Q2 2021 | -131.71% |
| Q1 2021 | 207.89% |
| Q4 2020 | 51.90% |
| Q3 2020 | -977.78% |
| Q2 2020 | 120.93% |
| Q1 2020 | -48.28% |
| Q4 2019 | 32.56% |
| Q3 2019 | 55.67% |
| Q2 2019 | -273.08% |
| Q1 2019 | 67.50% |
| Q4 2018 | -116.22% |
| Q3 2018 | 68.38% |
| Q2 2018 | -80.00% |
| Q1 2018 | 61.99% |
| Q4 2017 | 17.39% |
| Q3 2017 | 1.43% |
| Q2 2017 | -6.60% |
| Q1 2017 | 3.43% |
| Q4 2016 | -0.99% |
| Q3 2016 | 1.46% |
| Q2 2016 | 6.39% |
| Q1 2016 | -15.26% |